Antifungal activity of biogenic silver nanoparticles in combination with amphotericin B on Candida glabrata
- Autores
- Galera, Ivana Laura Delia; Páez, Paulina Laura; Paraje, María Gabriela
- Año de publicación
- 2021
- Idioma
- inglés
- Tipo de recurso
- documento de conferencia
- Estado
- versión publicada
- Descripción
- Non-albicans Candida (NAC) species cause 35-65% of all candidaemias in the general patient population. Among the NAC species, Candida glabrata is considered the second or third most frequent causative agent of superficial (oral, esophageal, urinary, and vaginal) or systemic infections, with a high mortality rate. These infections are difficult to treat for their innate resistance to many azole antifungals (ATF) therapy, especially fluconazole. Nowadays, current advances in nanotechnology constitute a promising alternative in the development of new antimicrobial agents. Silver nanoparticles (AgNPs) are very interesting products currently provided by available nanotechnology to evaluate their antifungal activity. In the present study, the synergism of AgNPs in combination with amphotericin B (AmB) against C. glabrata was investigated. Biogenic AgNPs were synthesized by eco-friendly method, and the antifungal activity against C. glabrata ATCC 2001 was evaluated through determination of Minimum Inhibitory Concentration (MIC50) and Minimum Fungicidal Concentration (MFC) according to protocol M27-A3 of Clinical and Laboratory Standards Institute (CLSI). The checkerboard microdilution method was used to study the synergistic combinations of AgNPs with AmB. The results were analyzed using the Fractionary Inhibitory Concentration (FIC) indices, a non-parametric model based on the Loewe additivity theory, and by CompuSyn software. CompuSyn is a computer program for quantitation of synergism and antagonism in drug combinations and the determination of IC50 (drug concentration causing 50% growth inhibition) and ED50 (dose causing 50% of maximum effect) values. Furthermore, we investigated the effects of the resazurin reduction (alamarBlue) assay, which measured metabolically active cells. The same MIC and MFC values were found for AgNP 0.13 pM and for AmB 2.7x105 pM. The FIC index was 0.37 (a FIC index of < 0.5 indicates synergism). This value corresponded to 0.033 pM AgNPs + 3.4 x 104 pM AmB (0.25 CIM AgNP + 0.125 CIM AmB) combination. Resazurin (blue, nonfluorescent) was reduced by metabolically active cells to resorufin (pink, fluorescent) showing the cytotoxic effect, which was visually weighted. The CompuSyn analysis confirmed synergism between biogenic AgNPs and AmB against C. glabrata. The analysis also shows that the maximal inhibitory activity of the combination is substantially expanded compared to those of the single agents. The IC50 was 0.08 CIM AgNPs and 0.06 CIM AmB (0.01 pM and 1.6x104 pM respectively). Isobolograms demonstrate a stark reduction of the AmB dose when used with AgNP to induce 50% inhibition or greater. Combined therapy has the advantage of attacking different targets by combining several active principles with different mechanisms of action. The development of new approaches has great clinical relevance in the treatment of mycoses.
Fil: Galera, Ivana Laura Delia. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba. Instituto Multidisciplinario de Biología Vegetal. Universidad Nacional de Córdoba. Facultad de Ciencias Exactas Físicas y Naturales. Instituto Multidisciplinario de Biología Vegetal; Argentina
Fil: Páez, Paulina Laura. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Departamento de Farmacia; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba. Unidad de Investigación y Desarrollo en Tecnología Farmacéutica. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Unidad de Investigación y Desarrollo en Tecnología Farmacéutica; Argentina
Fil: Paraje, María Gabriela. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba. Instituto Multidisciplinario de Biología Vegetal. Universidad Nacional de Córdoba. Facultad de Ciencias Exactas Físicas y Naturales. Instituto Multidisciplinario de Biología Vegetal; Argentina
LVII Annual Meeting of the Argentine Society for Biochemistry and Molecular Biology Research; XVI Annual Meeting of the Argentinean Society for General Microbiology
Argentina
Argentine Society for Biochemistry and Molecular Biology Research - Materia
-
Antifungal activity
Biogenic nanoparticles
Silver nanoparticles
Candida - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/176910
Ver los metadatos del registro completo
id |
CONICETDig_875ccfd164597ff99824896ea7f81849 |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/176910 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Antifungal activity of biogenic silver nanoparticles in combination with amphotericin B on Candida glabrataGalera, Ivana Laura DeliaPáez, Paulina LauraParaje, María GabrielaAntifungal activityBiogenic nanoparticlesSilver nanoparticlesCandidahttps://purl.org/becyt/ford/1.6https://purl.org/becyt/ford/1Non-albicans Candida (NAC) species cause 35-65% of all candidaemias in the general patient population. Among the NAC species, Candida glabrata is considered the second or third most frequent causative agent of superficial (oral, esophageal, urinary, and vaginal) or systemic infections, with a high mortality rate. These infections are difficult to treat for their innate resistance to many azole antifungals (ATF) therapy, especially fluconazole. Nowadays, current advances in nanotechnology constitute a promising alternative in the development of new antimicrobial agents. Silver nanoparticles (AgNPs) are very interesting products currently provided by available nanotechnology to evaluate their antifungal activity. In the present study, the synergism of AgNPs in combination with amphotericin B (AmB) against C. glabrata was investigated. Biogenic AgNPs were synthesized by eco-friendly method, and the antifungal activity against C. glabrata ATCC 2001 was evaluated through determination of Minimum Inhibitory Concentration (MIC50) and Minimum Fungicidal Concentration (MFC) according to protocol M27-A3 of Clinical and Laboratory Standards Institute (CLSI). The checkerboard microdilution method was used to study the synergistic combinations of AgNPs with AmB. The results were analyzed using the Fractionary Inhibitory Concentration (FIC) indices, a non-parametric model based on the Loewe additivity theory, and by CompuSyn software. CompuSyn is a computer program for quantitation of synergism and antagonism in drug combinations and the determination of IC50 (drug concentration causing 50% growth inhibition) and ED50 (dose causing 50% of maximum effect) values. Furthermore, we investigated the effects of the resazurin reduction (alamarBlue) assay, which measured metabolically active cells. The same MIC and MFC values were found for AgNP 0.13 pM and for AmB 2.7x105 pM. The FIC index was 0.37 (a FIC index of < 0.5 indicates synergism). This value corresponded to 0.033 pM AgNPs + 3.4 x 104 pM AmB (0.25 CIM AgNP + 0.125 CIM AmB) combination. Resazurin (blue, nonfluorescent) was reduced by metabolically active cells to resorufin (pink, fluorescent) showing the cytotoxic effect, which was visually weighted. The CompuSyn analysis confirmed synergism between biogenic AgNPs and AmB against C. glabrata. The analysis also shows that the maximal inhibitory activity of the combination is substantially expanded compared to those of the single agents. The IC50 was 0.08 CIM AgNPs and 0.06 CIM AmB (0.01 pM and 1.6x104 pM respectively). Isobolograms demonstrate a stark reduction of the AmB dose when used with AgNP to induce 50% inhibition or greater. Combined therapy has the advantage of attacking different targets by combining several active principles with different mechanisms of action. The development of new approaches has great clinical relevance in the treatment of mycoses.Fil: Galera, Ivana Laura Delia. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba. Instituto Multidisciplinario de Biología Vegetal. Universidad Nacional de Córdoba. Facultad de Ciencias Exactas Físicas y Naturales. Instituto Multidisciplinario de Biología Vegetal; ArgentinaFil: Páez, Paulina Laura. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Departamento de Farmacia; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba. Unidad de Investigación y Desarrollo en Tecnología Farmacéutica. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Unidad de Investigación y Desarrollo en Tecnología Farmacéutica; ArgentinaFil: Paraje, María Gabriela. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba. Instituto Multidisciplinario de Biología Vegetal. Universidad Nacional de Córdoba. Facultad de Ciencias Exactas Físicas y Naturales. Instituto Multidisciplinario de Biología Vegetal; ArgentinaLVII Annual Meeting of the Argentine Society for Biochemistry and Molecular Biology Research; XVI Annual Meeting of the Argentinean Society for General MicrobiologyArgentinaArgentine Society for Biochemistry and Molecular Biology ResearchTech Science Press2021info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/conferenceObjectCongresoJournalhttp://purl.org/coar/resource_type/c_5794info:ar-repo/semantics/documentoDeConferenciaapplication/pdfapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/176910Antifungal activity of biogenic silver nanoparticles in combination with amphotericin B on Candida glabrata; LVII Annual Meeting of the Argentine Society for Biochemistry and Molecular Biology Research; XVI Annual Meeting of the Argentinean Society for General Microbiology; Argentina; 2021; 124-1240327-95451667-5746CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://www.techscience.com/biocell/v46nSuppl.1/46213Nacionalinfo:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-29T09:42:18Zoai:ri.conicet.gov.ar:11336/176910instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-29 09:42:18.889CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Antifungal activity of biogenic silver nanoparticles in combination with amphotericin B on Candida glabrata |
title |
Antifungal activity of biogenic silver nanoparticles in combination with amphotericin B on Candida glabrata |
spellingShingle |
Antifungal activity of biogenic silver nanoparticles in combination with amphotericin B on Candida glabrata Galera, Ivana Laura Delia Antifungal activity Biogenic nanoparticles Silver nanoparticles Candida |
title_short |
Antifungal activity of biogenic silver nanoparticles in combination with amphotericin B on Candida glabrata |
title_full |
Antifungal activity of biogenic silver nanoparticles in combination with amphotericin B on Candida glabrata |
title_fullStr |
Antifungal activity of biogenic silver nanoparticles in combination with amphotericin B on Candida glabrata |
title_full_unstemmed |
Antifungal activity of biogenic silver nanoparticles in combination with amphotericin B on Candida glabrata |
title_sort |
Antifungal activity of biogenic silver nanoparticles in combination with amphotericin B on Candida glabrata |
dc.creator.none.fl_str_mv |
Galera, Ivana Laura Delia Páez, Paulina Laura Paraje, María Gabriela |
author |
Galera, Ivana Laura Delia |
author_facet |
Galera, Ivana Laura Delia Páez, Paulina Laura Paraje, María Gabriela |
author_role |
author |
author2 |
Páez, Paulina Laura Paraje, María Gabriela |
author2_role |
author author |
dc.subject.none.fl_str_mv |
Antifungal activity Biogenic nanoparticles Silver nanoparticles Candida |
topic |
Antifungal activity Biogenic nanoparticles Silver nanoparticles Candida |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/1.6 https://purl.org/becyt/ford/1 |
dc.description.none.fl_txt_mv |
Non-albicans Candida (NAC) species cause 35-65% of all candidaemias in the general patient population. Among the NAC species, Candida glabrata is considered the second or third most frequent causative agent of superficial (oral, esophageal, urinary, and vaginal) or systemic infections, with a high mortality rate. These infections are difficult to treat for their innate resistance to many azole antifungals (ATF) therapy, especially fluconazole. Nowadays, current advances in nanotechnology constitute a promising alternative in the development of new antimicrobial agents. Silver nanoparticles (AgNPs) are very interesting products currently provided by available nanotechnology to evaluate their antifungal activity. In the present study, the synergism of AgNPs in combination with amphotericin B (AmB) against C. glabrata was investigated. Biogenic AgNPs were synthesized by eco-friendly method, and the antifungal activity against C. glabrata ATCC 2001 was evaluated through determination of Minimum Inhibitory Concentration (MIC50) and Minimum Fungicidal Concentration (MFC) according to protocol M27-A3 of Clinical and Laboratory Standards Institute (CLSI). The checkerboard microdilution method was used to study the synergistic combinations of AgNPs with AmB. The results were analyzed using the Fractionary Inhibitory Concentration (FIC) indices, a non-parametric model based on the Loewe additivity theory, and by CompuSyn software. CompuSyn is a computer program for quantitation of synergism and antagonism in drug combinations and the determination of IC50 (drug concentration causing 50% growth inhibition) and ED50 (dose causing 50% of maximum effect) values. Furthermore, we investigated the effects of the resazurin reduction (alamarBlue) assay, which measured metabolically active cells. The same MIC and MFC values were found for AgNP 0.13 pM and for AmB 2.7x105 pM. The FIC index was 0.37 (a FIC index of < 0.5 indicates synergism). This value corresponded to 0.033 pM AgNPs + 3.4 x 104 pM AmB (0.25 CIM AgNP + 0.125 CIM AmB) combination. Resazurin (blue, nonfluorescent) was reduced by metabolically active cells to resorufin (pink, fluorescent) showing the cytotoxic effect, which was visually weighted. The CompuSyn analysis confirmed synergism between biogenic AgNPs and AmB against C. glabrata. The analysis also shows that the maximal inhibitory activity of the combination is substantially expanded compared to those of the single agents. The IC50 was 0.08 CIM AgNPs and 0.06 CIM AmB (0.01 pM and 1.6x104 pM respectively). Isobolograms demonstrate a stark reduction of the AmB dose when used with AgNP to induce 50% inhibition or greater. Combined therapy has the advantage of attacking different targets by combining several active principles with different mechanisms of action. The development of new approaches has great clinical relevance in the treatment of mycoses. Fil: Galera, Ivana Laura Delia. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba. Instituto Multidisciplinario de Biología Vegetal. Universidad Nacional de Córdoba. Facultad de Ciencias Exactas Físicas y Naturales. Instituto Multidisciplinario de Biología Vegetal; Argentina Fil: Páez, Paulina Laura. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Departamento de Farmacia; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba. Unidad de Investigación y Desarrollo en Tecnología Farmacéutica. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Unidad de Investigación y Desarrollo en Tecnología Farmacéutica; Argentina Fil: Paraje, María Gabriela. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba. Instituto Multidisciplinario de Biología Vegetal. Universidad Nacional de Córdoba. Facultad de Ciencias Exactas Físicas y Naturales. Instituto Multidisciplinario de Biología Vegetal; Argentina LVII Annual Meeting of the Argentine Society for Biochemistry and Molecular Biology Research; XVI Annual Meeting of the Argentinean Society for General Microbiology Argentina Argentine Society for Biochemistry and Molecular Biology Research |
description |
Non-albicans Candida (NAC) species cause 35-65% of all candidaemias in the general patient population. Among the NAC species, Candida glabrata is considered the second or third most frequent causative agent of superficial (oral, esophageal, urinary, and vaginal) or systemic infections, with a high mortality rate. These infections are difficult to treat for their innate resistance to many azole antifungals (ATF) therapy, especially fluconazole. Nowadays, current advances in nanotechnology constitute a promising alternative in the development of new antimicrobial agents. Silver nanoparticles (AgNPs) are very interesting products currently provided by available nanotechnology to evaluate their antifungal activity. In the present study, the synergism of AgNPs in combination with amphotericin B (AmB) against C. glabrata was investigated. Biogenic AgNPs were synthesized by eco-friendly method, and the antifungal activity against C. glabrata ATCC 2001 was evaluated through determination of Minimum Inhibitory Concentration (MIC50) and Minimum Fungicidal Concentration (MFC) according to protocol M27-A3 of Clinical and Laboratory Standards Institute (CLSI). The checkerboard microdilution method was used to study the synergistic combinations of AgNPs with AmB. The results were analyzed using the Fractionary Inhibitory Concentration (FIC) indices, a non-parametric model based on the Loewe additivity theory, and by CompuSyn software. CompuSyn is a computer program for quantitation of synergism and antagonism in drug combinations and the determination of IC50 (drug concentration causing 50% growth inhibition) and ED50 (dose causing 50% of maximum effect) values. Furthermore, we investigated the effects of the resazurin reduction (alamarBlue) assay, which measured metabolically active cells. The same MIC and MFC values were found for AgNP 0.13 pM and for AmB 2.7x105 pM. The FIC index was 0.37 (a FIC index of < 0.5 indicates synergism). This value corresponded to 0.033 pM AgNPs + 3.4 x 104 pM AmB (0.25 CIM AgNP + 0.125 CIM AmB) combination. Resazurin (blue, nonfluorescent) was reduced by metabolically active cells to resorufin (pink, fluorescent) showing the cytotoxic effect, which was visually weighted. The CompuSyn analysis confirmed synergism between biogenic AgNPs and AmB against C. glabrata. The analysis also shows that the maximal inhibitory activity of the combination is substantially expanded compared to those of the single agents. The IC50 was 0.08 CIM AgNPs and 0.06 CIM AmB (0.01 pM and 1.6x104 pM respectively). Isobolograms demonstrate a stark reduction of the AmB dose when used with AgNP to induce 50% inhibition or greater. Combined therapy has the advantage of attacking different targets by combining several active principles with different mechanisms of action. The development of new approaches has great clinical relevance in the treatment of mycoses. |
publishDate |
2021 |
dc.date.none.fl_str_mv |
2021 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/publishedVersion info:eu-repo/semantics/conferenceObject Congreso Journal http://purl.org/coar/resource_type/c_5794 info:ar-repo/semantics/documentoDeConferencia |
status_str |
publishedVersion |
format |
conferenceObject |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/176910 Antifungal activity of biogenic silver nanoparticles in combination with amphotericin B on Candida glabrata; LVII Annual Meeting of the Argentine Society for Biochemistry and Molecular Biology Research; XVI Annual Meeting of the Argentinean Society for General Microbiology; Argentina; 2021; 124-124 0327-9545 1667-5746 CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/176910 |
identifier_str_mv |
Antifungal activity of biogenic silver nanoparticles in combination with amphotericin B on Candida glabrata; LVII Annual Meeting of the Argentine Society for Biochemistry and Molecular Biology Research; XVI Annual Meeting of the Argentinean Society for General Microbiology; Argentina; 2021; 124-124 0327-9545 1667-5746 CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/https://www.techscience.com/biocell/v46nSuppl.1/46213 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf application/pdf |
dc.coverage.none.fl_str_mv |
Nacional |
dc.publisher.none.fl_str_mv |
Tech Science Press |
publisher.none.fl_str_mv |
Tech Science Press |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1844613333076934656 |
score |
13.069144 |